Boehringer Ingelheim completes new chemical R&D and production site in Shanghai’s Zhangjiang park

With investments of nearly 70 million €, production capacity will expand 3-fold by 2018, with up to 350 employees.

China Bio news release, Sept. 26, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny